Neurotransmitter balance modulation

Neurotransmitter balance modulation refers to the physiological or therapeutic regulation of neurotransmitter concentrations, release, receptor activation, or reuptake within the nervous system. Disruption in neurotransmitter balance is implicated in a wide range of neurological and psychiatric disorders, including Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, and others[5][1][6]. This process does not refer to a single molecule but to the collective actions exerted on multiple targets (such as enzymes for neurotransmitter synthesis and degradation, receptor subtypes, and membrane transporters) aimed at maintaining optimal neurotransmission and neuronal homeostasis[1][3][5]. Therapies and drugs in this context act through distinct but interconnected mechanisms to restore or optimize neurotransmitter balance, often by inhibiting breakdown enzymes (e.g., monoamine oxidase inhibitors), blocking or activating specific neurotransmitter receptors (e.g., antipsychotics, antidepressants), or modulating reuptake transporters (e.g., SSRIs, SNRIs). As such, “neurotransmitter balance modulation” is a process or therapeutic strategy, not an individual molecular target.

Other names

Neurotransmitter homeostasisNeurotransmitter regulationModulation of neurotransmitter levels

Inhibition or enhancement of neurotransmitter synthesis; Modulation of neurotransmitter receptor activity; Inhibition of neurotransmitter degradation; Modulation of neurotransmitter transporter function